Tonghua Dongbao Pharmaceutical Co Ltd Financial Flexibility Index
Tonghua Dongbao Pharmaceutical Co Ltd financial flexibility index. Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Financial Flexibility Index of 0.21x as of September 2025. Free cash flow of CN¥213.57 Million (operating CF CN¥62.99 Million minus capex CN¥150.58 Million) represents 0% of total liabilities (CN¥1.02 Billion). See Tonghua Dongbao Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Financial flexibility index of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Tonghua Dongbao Pharmaceutical Co Ltd across 28 annual periods. Check Tonghua Dongbao Pharmaceutical Co Ltd (600867) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Tonghua Dongbao Pharmaceutical Co Ltd Financial Flexibility Index by Year (1998–2025)
Tonghua Dongbao Pharmaceutical Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Tonghua Dongbao Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Tonghua Dongbao Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.51x | CN¥1.21 Billion | CN¥689.23 Million | CN¥798.84 Million | ▲ +43.7% |
| 2024 | 1.05x | CN¥1.03 Billion | CN¥459.74 Million | CN¥978.08 Million | ▼ -51.7% |
| 2023 | 2.18x | CN¥1.21 Billion | CN¥861.52 Million | CN¥555.08 Million | ▼ -67.7% |
| 2022 | 6.75x | CN¥1.35 Billion | CN¥863.09 Million | CN¥200.74 Million | ▲ +16.6% |
| 2021 | 5.79x | CN¥1.74 Billion | CN¥1.13 Billion | CN¥299.87 Million | ▼ -15.6% |
| 2020 | 6.86x | CN¥1.67 Billion | CN¥1.19 Billion | CN¥243.80 Million | ▲ +61.8% |
| 2019 | 4.24x | CN¥1.45 Billion | CN¥1.15 Billion | CN¥341.10 Million | ▲ +87.2% |
| 2018 | 2.26x | CN¥1.65 Billion | CN¥876.94 Million | CN¥729.06 Million | ▼ -57.5% |
| 2017 | 5.33x | CN¥1.15 Billion | CN¥961.19 Million | CN¥215.30 Million | ▲ +241.8% |
| 2016 | 1.56x | CN¥1.14 Billion | CN¥725.76 Million | CN¥729.76 Million | ▲ +193.7% |
| 2015 | 0.53x | CN¥694.67 Million | CN¥294.58 Million | CN¥1.31 Billion | ▲ +35.3% |
| 2014 | 0.39x | CN¥311.97 Million | CN¥205.89 Million | CN¥795.72 Million | ▼ -35.4% |
| 2013 | 0.61x | CN¥411.41 Million | CN¥221.06 Million | CN¥678.23 Million | ▼ -45.9% |
| 2012 | 1.12x | CN¥436.15 Million | CN¥194.32 Million | CN¥388.92 Million | ▲ +894.5% |
| 2011 | 0.11x | CN¥33.76 Million | CN¥-55.07 Million | CN¥299.37 Million | ▼ -78.0% |
| 2010 | 0.51x | CN¥233.05 Million | CN¥160.40 Million | CN¥453.75 Million | ▲ +30.8% |
| 2009 | 0.39x | CN¥245.27 Million | CN¥166.20 Million | CN¥624.75 Million | ▲ +94.4% |
| 2008 | 0.20x | CN¥148.98 Million | CN¥92.31 Million | CN¥737.66 Million | ▼ -60.9% |
| 2007 | 0.52x | CN¥379.28 Million | CN¥120.94 Million | CN¥734.97 Million | ▼ -19.8% |
| 2006 | 0.64x | CN¥444.90 Million | CN¥158.00 Million | CN¥691.13 Million | ▲ +65.6% |
| 2005 | 0.39x | CN¥211.61 Million | CN¥92.23 Million | CN¥544.23 Million | ▲ +199.9% |
| 2004 | 0.13x | CN¥62.24 Million | CN¥13.17 Million | CN¥480.12 Million | ▼ -50.6% |
| 2003 | 0.26x | CN¥103.40 Million | CN¥45.51 Million | CN¥393.95 Million | ▼ -55.6% |
| 2002 | 0.59x | CN¥121.41 Million | CN¥31.99 Million | CN¥205.52 Million | ▼ -77.7% |
| 2001 | 2.65x | CN¥206.42 Million | CN¥117.73 Million | CN¥77.96 Million | ▲ +43.1% |
| 2000 | 1.85x | CN¥81.58 Million | CN¥29.12 Million | CN¥44.10 Million | ▲ +17.6% |
| 1999 | 1.57x | CN¥145.90 Million | CN¥-95.09 Million | CN¥92.79 Million | ▲ +295.9% |
| 1998 | -0.80x | CN¥-200.49 Million | CN¥-216.98 Million | CN¥249.82 Million | — |